Authors’ Reply to the Letter to the Editor by May et al: Optimized Prognostic Stratification in PSCC

Authors:
Jad Chahoud Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Search for other papers by Jad Chahoud in
Current site
Google Scholar
PubMed
Close
 MD, MPH
and
Philippe E. Spiess Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Search for other papers by Philippe E. Spiess in
Current site
Google Scholar
PubMed
Close
 MD
Restricted access
  • Collapse
  • Expand
  • 1.

    May M, Hrudka J, Elst L, Regauer S. Letter to the editor: advancing prognostic stratification in PSCC: developing predictive models as the next pivotal step. J Natl Compr Canc Netw 2025;23:e257038.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Mustasam A, Parza K, Ionescu F, et al. The prognostic role of HPV or p16INK4a status in penile squamous cell carcinoma: a meta-analysis. J Natl Compr Canc Netw 2025;23:e247078.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    Chahoud J, Zacharias NM, Pham R, et al. Prognostic significance of p16 and Its relationship with human papillomavirus status in patients with penile squamous cell carcinoma: results of 5 years follow-up. Cancers (Basel) 2022;14:6024.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Elst L, Philips G, Vandermaesen K, et al. Single-cell atlas of penile cancer reveals TP53 mutations as a driver of an aggressive phenotype, irrespective of human papillomavirus status, and provides clues for treatment personalization. Eur Urol 2024;86:114127.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5.

    Chahoud J, Yu X, Necchi A, Spiess PE. TP53 mutations emerge as a critical biomarker in penile cancer, superseding human papillomavirus status. Eur Urol 2024;86:128129.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6.

    Cigliola A, Prakash G, Li R, et al. Current status and challenges in rare genitourinary cancer research and future directions. Curr Oncol Rep 2024;26:977990.

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 162 162 162
PDF Downloads 45 45 45
EPUB Downloads 0 0 0